Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Blood Cells, Molecules & Diseases|February 4, 2014
DNA damage response in adult stem cellsAlessandra Insinga, Angelo Cicalese, Pier Giuseppe PelicciCell Cycle (Georgetown, Tex.)|December 22, 2004
Leukemia-associated fusion proteins. Multiple mechanisms of action to drive cell transformationAlessandra Insinga, Pier Giuseppe Pelicci, Saverio InucciCell Cycle (Georgetown, Tex.)|May 24, 2005
Mechanisms of selective anticancer action of histone deacetylase inhibitorsAlessandra Insinga, Saverio Minucci, Pier Giuseppe PelicciJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Management of ovarian stromal cell tumorsNicoletta Colombo, Gabriella Parma, Vanna Zanagnolo, et al.Trends in Molecular Medicine|September 13, 2011
The emerging role of p53 in stem cellsGiuseppina Bonizzi, Angelo Cicalese, Alessandra Insinga, et al.Cell|May 7, 2003
Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with SmadsMichelangelo Cordenonsi, Sirio Dupont, Silvia Maretto, et al.Molecular and Cellular Biology|February 2, 2006
Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion proteinRoberta Carbone, Oronza A Botrugno, Simona Ronzoni, et al.The Journal of Biological Chemistry|May 2, 2003
Interaction of glycoprotein H of human herpesvirus 6 with the cellular receptor CD46Fabio Santoro, Heather L Greenstone, Alessandra Insinga, et al.Proceedings of the National Academy of Sciences of the United States of America|February 19, 2013
DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisionsAlessandra Insinga, Angelo Cicalese, Mario Faretta, et al.The EMBO Journal|February 21, 2004
Impairment of p53 acetylation, stability and function by an oncogenic transcription factorAlessandra Insinga, Silvia Monestiroli, Simona Ronzoni, et al.Pageof 2